What do systematic reviews say?

RAS inhibitors vs beta‐blocker

RAS inhibitors showed no clear difference in total myocardial infarction compared with beta‐blockers (low certainty).

• First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for… 2018 · Cochrane Headline outcomes only
  RR 1.05 [0.86, 1.27]
  2 studies · 9239 participants
  Low